Cronos Group Inc is seeing a significant drop in its stock price, reflecting ongoing challenges in the cannabis sector.
Today, Cronos Group Inc (CRON.TO) fell by 3.97%, closing at CA$4.24. This decline comes as the cannabis industry faces turbulence, with competitors like Canopy Growth and Aurora Cannabis showing mixed performance, emphasizing the sector's volatility.
Advertisement
Cronos Group Inc
CRON.TO
CRON.TO
Cronos Group Inc
WealthAwesomeAdvertisement
Market cap
$1.62B
P/E
17.0x
52W high
$4.66
52W low
$3.23
1W change
+2.08%
Beta
1.24
Analyst Price Targets
Based on analyst covering CRON
Wall Street analysts forecast CRON stock price to rise 11.7% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$4.92
+11.7% Upside
Current Price
C$4.41
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRON's historical volatility
30-Day Vol
46.8%
Annualized
90-Day Vol
41.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$5.27
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$4.68 | C$3.98 – C$5.50 |
| 60 trading days | C$4.97 | C$3.95 – C$6.24 |
| 90 trading days | C$5.27 | C$3.99 – C$6.97 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as Cronos Group's stock struggles to gain traction amid broader sector challenges, which could affect future profitability.
Cronos Group Inc's stock down 3.97% today
The stock's decline raises concerns about the sustainability of growth in the cannabis market.
Bull case
Despite today's drop, Cronos Group recently reported record revenue for Q2, suggesting there’s potential for recovery if market conditions improve.
Bear case
The cannabis sector remains unpredictable, and Cronos Group's recent performance might indicate deeper issues that could slow its growth.
Market Context
Advertisement
Today's decline in Cronos Group's stock is part of a larger trend affecting cannabis companies. While Canopy Growth reported a 13% increase in revenue, Cronos's performance stands in stark contrast, highlighting the competitive pressures in the industry.
Financial Performance
Cronos Group's latest earnings report showed record Q2 revenue, but investor sentiment is still cautious. The 3.97% drop today raises questions about the company's ability to maintain growth in a tough market.
Looking Ahead
As Cronos Group navigates the complexities of the cannabis market, investors should keep a close eye on upcoming developments. The company's ability to adapt to market changes will be crucial for its stock performance in the months ahead.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
